Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Ricarda Graf"'
Autor:
Helena Sorger, Saptaswa Dey, Pablo Augusto Vieyra‐Garcia, Daniel Pölöske, Andrea R Teufelberger, Elvin D de Araujo, Abootaleb Sedighi, Ricarda Graf, Benjamin Spiegl, Isaac Lazzeri, Till Braun, Ines Garces de los Fayos Alonso, Michaela Schlederer, Gerald Timelthaler, Petra Kodajova, Christine Pirker, Marta Surbek, Michael Machtinger, Thomas Graier, Isabella Perchthaler, Yi Pan, Regina Fink‐Puches, Lorenzo Cerroni, Jennifer Ober, Moritz Otte, Jana D Albrecht, Gary Tin, Ayah Abdeldayem, Pimyupa Manaswiyoungkul, Olasunkanmi O Olaoye, Martin L Metzelder, Anna Orlova, Walter Berger, Marion Wobser, Jan P Nicolay, Fiona André, Van Anh Nguyen, Heidi A Neubauer, Roman Fleck, Olaf Merkel, Marco Herling, Ellen Heitzer, Patrick T Gunning, Lukas Kenner, Richard Moriggl, Peter Wolf
Publikováno v:
EMBO Molecular Medicine, Vol 14, Iss 12, Pp 1-23 (2022)
Abstract Leukemic cutaneous T‐cell lymphomas (L‐CTCL) are lymphoproliferative disorders of skin‐homing mature T‐cells causing severe symptoms and high mortality through chronic inflammation, tissue destruction, and serious infections. Despite
Externí odkaz:
https://doaj.org/article/c1ee8bac3c164d9b80fc189cf3bc69bf
Autor:
Nadia Dandachi, Florian Posch, Ricarda Graf, Christoph Suppan, Eva Valentina Klocker, Hannah Deborah Müller, Jörg Lindenmann, Angelika Terbuch, Ellen Heitzer, Marija Balic
Publikováno v:
Molecular Oncology, Vol 15, Iss 9, Pp 2390-2400 (2021)
Despite improved clinical outcomes, intrinsic or acquired resistance to CDK4/6 inhibitor treatment has limited the success of this treatment in HR+HER2− metastatic breast cancer patients. Biomarkers are urgently needed, and longitudinal biomarker m
Externí odkaz:
https://doaj.org/article/117d480dafe543e89c6b08c0fd35a25b
Autor:
Harry J M Groen, Qing Zhou, Ellen Heitzer, Michael R Speicher, Ed Schuuring, Samantha O Perakis, Sabrina Weber, Ricarda Graf, Sabine Hojas, Jakob M Riedl, Armin Gerger, Nadia Dandachi, Marija Balic, Gerald Hoefler, Jochen B Geigl
Publikováno v:
ESMO Open, Vol 5, Iss 5 (2020)
Objective Precision oncology depends on translating molecular data into therapy recommendations. However, with the growing complexity of next-generation sequencing-based tests, clinical interpretation of somatic genomic mutations has evolved into a f
Externí odkaz:
https://doaj.org/article/98ddadfdad874cbf99c15c5ec5afd03d
Autor:
Muhammad Muzammal, Muhammad Zubair, Sophie Bierbaumer, Jasmin Blatterer, Ricarda Graf, Aisha Gul, Safdar Abbas, Muhammad Badar, Ansar Ahmad Abbasi, Muzammil Ahmad Khan, Christian Windpassinger
Publikováno v:
Molecular Genetics & Genomic Medicine, Vol 7, Iss 8, Pp n/a-n/a (2019)
Abstract Background Bardet‐Biedl syndrome (BBS) is characterized by a heterogeneous phenotypic spectrum of retinopathy, intellectual disability (ID), obesity, polydactyly, and kidney dysfunctions as the major clinical features. Genetic investigatio
Externí odkaz:
https://doaj.org/article/c14d0cf50a7647c09a201c5632d1b792
Autor:
Peter Ulz, Jelena Belic, Ricarda Graf, Martina Auer, Ingrid Lafer, Katja Fischereder, Gerald Webersinke, Karl Pummer, Herbert Augustin, Martin Pichler, Gerald Hoefler, Thomas Bauernhofer, Jochen B. Geigl, Ellen Heitzer, Michael R. Speicher
Publikováno v:
Nature Communications, Vol 7, Iss 1, Pp 1-12 (2016)
The genomic features of metastatic prostate cancer are beginning to be understood. Here, the authors performed whole genome sequencing of plasma samples from these patients and found a high plasticity of the cancer genomes with newly occurring focal
Externí odkaz:
https://doaj.org/article/e51914e35344497896933a5afa0a6ac1
Autor:
Ellen Heitzer, Marija Balic, Michael Gnant, Martin Filipits, Nadia Dandachi, Sabrina Weber, Ricarda Graf, Anders Ståhlberg, Margaretha Rudas, Christian Fesl, Zsuzsanna Bago-Horvath, Peter C. Dubsky, Edgar Petru, Angelika Pichler, Viktor Wette, Rupert Bartsch, Georg Pfeiler, Daniel Egle, Christian F. Singer, Gabriel Rinnerthaler, Sophie Frantal, Simon P. Gampenrieder, Qing Zhou
Purpose:Accurate response assessment during neoadjuvant systemic treatment (NST) poses a clinical challenge. Therefore, a minimally invasive assessment of tumor response based on cell-free circulating tumor DNA (ctDNA) may be beneficial to guide trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47ed243da79c1c37626cfbc7ae763edc
https://doi.org/10.1158/1078-0432.c.6532496
https://doi.org/10.1158/1078-0432.c.6532496
Autor:
Ellen Heitzer, Marija Balic, Michael Gnant, Martin Filipits, Nadia Dandachi, Sabrina Weber, Ricarda Graf, Anders Ståhlberg, Margaretha Rudas, Christian Fesl, Zsuzsanna Bago-Horvath, Peter C. Dubsky, Edgar Petru, Angelika Pichler, Viktor Wette, Rupert Bartsch, Georg Pfeiler, Daniel Egle, Christian F. Singer, Gabriel Rinnerthaler, Sophie Frantal, Simon P. Gampenrieder, Qing Zhou
Supplementary Figure from Persistence of ctDNA in Patients with Breast Cancer During Neoadjuvant Treatment Is a Significant Predictor of Poor Tumor Response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11bc36db6ecc63d35820191d0eb5f100
https://doi.org/10.1158/1078-0432.22487330
https://doi.org/10.1158/1078-0432.22487330
Autor:
Ellen Heitzer, Marija Balic, Michael Gnant, Martin Filipits, Nadia Dandachi, Sabrina Weber, Ricarda Graf, Anders Ståhlberg, Margaretha Rudas, Christian Fesl, Zsuzsanna Bago-Horvath, Peter C. Dubsky, Edgar Petru, Angelika Pichler, Viktor Wette, Rupert Bartsch, Georg Pfeiler, Daniel Egle, Christian F. Singer, Gabriel Rinnerthaler, Sophie Frantal, Simon P. Gampenrieder, Qing Zhou
Supplementary Table from Persistence of ctDNA in Patients with Breast Cancer During Neoadjuvant Treatment Is a Significant Predictor of Poor Tumor Response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e466503ce14d784db53d6e97b43b5c0
https://doi.org/10.1158/1078-0432.22487306
https://doi.org/10.1158/1078-0432.22487306
Autor:
Zsuzsanna Bago-Horvath, Anders Ståhlberg, Christian F. Singer, Michael Gnant, Georg Pfeiler, Marija Balic, Christian Fesl, Edgar Petru, Nadia Dandachi, Sophie Frantal, Gabriel Rinnerthaler, Daniel Egle, Martin Filipits, Ellen Heitzer, Ricarda Graf, Simon Peter Gampenrieder, Viktor Wette, Sabrina Weber, Rupert Bartsch, Margaretha Rudas, Peter Dubsky, Angelika Pichler, Qing Zhou
Publikováno v:
Clinical Cancer Research. 28:697-707
Purpose: Accurate response assessment during neoadjuvant systemic treatment (NST) poses a clinical challenge. Therefore, a minimally invasive assessment of tumor response based on cell-free circulating tumor DNA (ctDNA) may be beneficial to guide tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6afc4c1deafde4c52696783b05742ac
https://doi.org/10.1158/1078-0432.ccr-21-3231
https://doi.org/10.1158/1078-0432.ccr-21-3231
Autor:
Sabrina Weber, Harry J.M. Groen, Hylke C. Donker, Paul van der Leest, T. Jeroen N. Hiltermann, Menno Tamminga, Ellen Heitzer, Thomas Schlange, Grigory Sidorenkov, Wim Timens, Leon W.M.M. Terstappen, Ed Schuuring, Michael R. Speicher, Samantha O Hasenleithner, Ricarda Graf, Tina Moser, Benjamin Spiegl, Marie-Laure Yaspo
Publikováno v:
JCO Precision Oncology, 5(5), 1540-1553. AMER SOC CLINICAL ONCOLOGY
JCO Precision Oncology, 5, 1540-1553. American Society of Clinical Oncology
JCO Precision Oncology, 5, 1540-1553. AMER SOC CLINICAL ONCOLOGY
JCO Precision Oncology, 5, 1540-1553. American Society of Clinical Oncology
JCO Precision Oncology, 5, 1540-1553. AMER SOC CLINICAL ONCOLOGY
PURPOSE Immune checkpoint inhibitors (ICIs) are increasingly being used in non–small-cell lung cancer (NSCLC), yet biomarkers predicting their benefit are lacking. We evaluated if on-treatment changes of circulating tumor DNA (ctDNA) from ICI start
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cde702c93ab154b75a7806adec551d0
https://hdl.handle.net/11370/e14d18e8-e351-4424-95f3-52396f148084
https://hdl.handle.net/11370/e14d18e8-e351-4424-95f3-52396f148084